Probiont
Biotechnology Research • 
Helsinki, Uusimaa, Finland • 1-10 Employees
Company overview
| Headquarters | Haartmaninkatu 4, Helsinki, Uusimaa 00290, FI |
| Phone number | +3581400290 |
| Website | |
| NAICS | 541714 |
| Keywords | Medical Device, Immunotherapy, Cancer Treatment, Cancer Technology, Cancer-On-A-Chip |
| Employees | 1-10 |
Key Contact at Probiont
Benedek Poor
CEO Founder
About Probiont
Probiont is developing cancer-on-a-chip technology that will enable rapid screening of cancer drugs used in immunotherapy for early identification of effective treatments for patients.
Probiont revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Probiont has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Probiont has never raised funding before.
Probiont Tech Stack
Discover the technologies and tools that power Probiont's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Web servers
UI frameworks
Programming languages
Webmail
Page builders
Blogs
SSL/TLS certificate authorities
Performance
Databases
JavaScript libraries
Miscellaneous
United States
United Kingdom
Canada
Croatia
Frequently asked questions
4.8
40,000 users
